Innovative drugmakers challenged to increase affordability
China’s leadership renews commitment to cut drug prices; biologics largely immune
By Shannon Ellis
Wednesday, December 11, 2013
SHANGHAI – After a flurry of high-level meetings discussing China’s drug pricing, the new leadership said it will continue to apply pressure on drug prices to reduce the cost of healthcare, but will make greater use of market forces.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.